← All candidates
11 insider filings on record.
22 filings on record.
LBRXLB PHARMACEUTICALS INC
NasdaqGM · Healthcare · $1.60B
$44.84
+0.47% · Sep 14
11 insider filings on record.
None of them an open-market buy in the last year.
Price · 1Y · daily◆ 4 8-K
▸ hover a marker for the filing · drag to zoom · daily bars sharpen to 30-min on close ranges · 4 moves explained
AI brief · from the filings on this pagePro
The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.
Market cap
$1.60B
Float
26.5M
82% public
Short % float
Pro
The buyers
▸ each insider's past open-market buys, measured ~6 months (120 trading days) later, against the S&P over the same spans · split-adjusted · pre-scheduled 10b5-1 plan trades excluded · past outcomes, not predictions
10% owner
Deep Track Biotechnology Master Fund, Ltd.
Bought $30.00M on Sep 12 — 2,000,000 sh @ $15.00, held direct, 75% of their stake.
1 of 1 position beat the S&P
10% owner
Pontifax Management 4 G.P. (2015) Ltd.
Bought $15.00M on Sep 12 — 1,000,000 sh @ $15.00, held indirect, 71% of their stake.
1 of 1 position beat the S&P
Director
Nussbaum Ran
Bought $15.00M on Sep 12 — 1,000,000 sh @ $15.00, held indirect, 71% of their stake.
1 of 1 position beat the S&P
The record
newest first
DateTypeInsiderOf stakeShares @ priceValue
6 more transactions on Pro →Context
Wall St
$45.00 avg target
+0.4% vs today · 7 analysts · consensus Strong Buy
▸ relayed analyst opinion, which tends to run optimistic — not our forecast or advice
Earnings · EPS vs forecast
0 of 2 quarters beat
Q4 '25−$0.45 act−$0.13
Q3 '25−$0.61 act−$0.33
Coverage
LB Pharmaceuticals Inc. (LBRX) Maintains Buy Rating as Analyst Highlights LB-102 PotentialInsider Monkey · 07-02All You Need to Know About LB Pharmaceuticals Inc (LBRX) Rating Upgrade to BuyZacks · 05-26LB Pharmaceuticals (NASDAQ:LBRX) Is In A Good Position To Deliver On Growth PlansSimply Wall St. · 05-14Nan Fung Group Sells $4.3 Million in Oculis Shares As Lead Drug StumblesMotley Fool · 06-08
The file stays open
22 filings on record.
The next one will be too.
▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice